Search
Search Results
##search.searchResults.foundPlural##
-
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
638PDF: 379Html: 37 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
3094PDF: 1082HTML: 2134 -
MANAGEMENT OF PORTAL VEIN THROMBOSIS IN CIRRHOTIC PATIENTS
861PDF: 579HTML: 4040 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
2381PDF: 1873HTML: 959 -
ZYGOMYCOSIS IN IMMUNOCOMPROMISED NON-HAEMATOLOGICAL PATIENTS
3013PDF: 1029HTML: 7505 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4741PDF: 2025HTML: 18187 -
CLINICAL AND LABORATORY FEATURES OF SICKLE CELL DISEASE S/D PUNJAB: IMPACT OF HBF AND HYDROXYUREA SCD S/D Punjab
1435PDF: 1214HTML: 157 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
2618PDF: 1257HTML: 1087 -
SIMPLE PERIPHERAL BLOOD SMEAR FINDINGS OF COVID-19 PATIENTS PROVIDE INFORMATION ABOUT THE SEVERITY OF THE DISEASE AND THE DURATION OF HOSPITAL STAY. Peripheral blood smear and COVID-19 severity.
3669PDF: 1268HTML: 517 -
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE
3744PDF: 1180HTML: 23381 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2434PDF: 1384HTML: 17214Bassan Fig.1: 176Bassan Fig.2: 282Bassan Fig.4: 168Fig.3: 251 -
HEPARIN-BINDING PROTEIN AS A DIAGNOSTIC AND PROGNOSTIC MARKER OF INFECTIONS: A SYSTEMATIC REVIEW AND META-ANALYSIS Heparin-binding protein in adult patients
3233PDF: 1098HTML: 333Suppl. Files: 539 -
EXTREMELY OLD PATIENTS HOSPITALIZED IN INTERNAL MEDICINE: WHAT ABOUT THEIR ANEMIA? Anemia in the elderly
1807PDF: 582HTML: 313 -
-
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1417PDF: 798HTML: 417 -
A 9month-old-boy with atypical hemophagocytic lymphohistiocytosis
2147PDF: 860HTML: 1232 -
NF- ?B Essential Modulator Deficiency Leading to Disseminated Cutaneous Atypical Mycobacteria
2162PDF: 1168HTML: 10764Untitled: 236 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
3041PDF: 1161HTML: 134 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2624PDF: 1389HTML: 1843CoverLetter: 223 -
-
Invasive Pulmonary Aspergillosis in a Sickle Cell Patient Transplant Recipient: A Successful Treatment
2058PDF: 1181HTML: 1936Lung computed tomography CT scan image: 235 -
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3855PDF: 1352HTML: 1741Untitled: 208 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1486PDF: 743HTML: 1191Untitled: 218Untitled: 182Untitled: 171Untitled: 188Untitled: 203 -
EFFICACY AND SAFETY OF SINOPHARM VACCINE FOR SARS-COV-2 AND BREAKTHROUGH INFECTIONS IN IRANIAN PATIENTS WITH HEMOGLOBINOPATHIES: A PRELIMINARY REPORT Sinopharm Vaccination in Iranian Patients with Hemoglobinopathies
1815PDF: 785HTML: 246 -
Sickle cell disease and Bartonella spp. infection
1390PDF: 1443HTML: 498 -
Glucocorticoids and antivirals for HBV reactivation in onco-hematologic patients
1045PDF: 602HTML: 2231Cover Letter: 230 -
ROLE OF CYTOKINES AS MOLECULAR MARKER OF DENGUE SEVERITY
3330PDF: 1241HTML: 508 -
IRON DEFICIENCY ANAEMIA AMONG PRE-SCHOOL CHILDREN WITH SICKLE CELL ANAEMIA: STILL A RARE DIAGNOSIS?
1516PDF: 875HTML: 2958cover leer: 188 -
PEDIATRIC MASTOCYTOSIS: AN UPDATE Chldren' Mastocytosis
2076HTML: 1692PDF: 1185 -
COMPARISON OF INFECTIOUS COMPLICATIONS IN PATIENTS RECEIVING HIGH-DOSE CYCLOPHOSPHAMIDE AS GVHD AFTER TRANSPLANTATION FROM A 9/10 HLA-MATCHED UNRELATED DONOR WITH STANDARD GVHD PROPHYLAXIS AFTER TRANSPLANT FROM A FULL MATCHING DONOR Infection With PTCy Versus Standard GvHD Prophylaxis
1550PDF: 1392HTML: 120 -
ANTIBACTERIAL RESISTANCE IN PATIENTS WITH HEMATOPOIETIC STEM CELL TRANSPLANTATION
4201PDF: 1320HTML: 2122Table 1: 232







